Mail

UK markets closed

FTSE 100
7,897.33
+20.28(+0.26%)
FTSE 250
19,394.19
-56.48(-0.29%)
AIM
744.49
-0.80(-0.11%)
GBP/EUR
1.1632
-0.0051(-0.44%)
GBP/USD
1.2412
-0.0026(-0.21%)
Bitcoin GBP
52,035.83
+727.66(+1.42%)

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Community Health Systems, Inc. (CYH)

NYSE - Nasdaq Real-time price. Currency in USD

Add to watchlist

2.8700

+0.0900

(+3.24%)

As of 11:33AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	386.37M
Enterprise value	12.52B
Trailing P/E	16.89
Forward P/E	10.14
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.03
Price/book (mrq)	N/A
Enterprise value/revenue	1.00
Enterprise value/EBITDA	8.11

Trading information

Stock price history

Beta (5Y monthly)	1.55
52-week change ³	-52.88%
S&P500 52-week change ³	21.23%
52-week high ³	6.5300
52-week low ³	2.0100
50-day moving average ³	3.1720
200-day moving average ³	3.2387

Share statistics

Avg vol (3-month) ³	2.06M
Avg vol (10-day) ³	1.67M
Shares outstanding ⁵	138.98M
Implied shares outstanding ⁶	138.98M
Float ⁸	97.15M
% held by insiders ¹	8.19%
% held by institutions ¹	71.62%
Shares short (28 Mar 2024) ⁴	6.32M
Short ratio (28 Mar 2024) ⁴	3.1
Short % of float (28 Mar 2024) ⁴	5.02%
Short % of shares outstanding (28 Mar 2024) ⁴	4.55%
Shares short (prior month 29 Feb 2024) ⁴	7.02M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	28 Dec 2012
Ex-dividend date ⁴	13 Dec 2012
Last split factor ²	121:100
Last split date ³	22 Apr 2016

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-1.07%
Operating margin (ttm)	7.82%

Management effectiveness

Return on assets (ttm)	3.73%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	12.49B
Revenue per share (ttm)	95.75
Quarterly revenue growth (yoy)	1.30%
Gross profit (ttm)	N/A
EBITDA	1.3B
Net income avi to common (ttm)	-133M
Diluted EPS (ttm)	-1.0200
Quarterly earnings growth (yoy)	-88.70%

Balance sheet

Total cash (mrq)	38M
Total cash per share (mrq)	0.29
Total debt (mrq)	12.17B
Total debt/equity (mrq)	N/A
Current ratio (mrq)	1.50
Book value per share (mrq)	-10.65

Cash flow statement

Operating cash flow (ttm)	210M
Levered free cash flow (ttm)	-142.25M